Article
Nrf2 activator-encapsulating polymeric nanoparticles and LDL-like nanoparticles target atherosclerotic plaque
2020-06-11
Abstract excerpt
Atherosclerotic vascular disease is the leading cause of death world-wide with few novel therapies available in spite of the ongoing health burden. Oxidative stress is a well-established driver of atherosclerotic progression; however the clinical translation of redox-based therapies is lacking. One of the challenges facing redox-based therapies is their targeted delivery to cellular domains of redox dysregulation....
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- b2861e79-6273-59ca-a3b2-f3be90126d73
- DOI
- 10.1101/2020.06.10.144451
